NuVasive (NUVA) PT Raised to $72 at Jefferies
Get Alerts NUVA Hot Sheet
Rating Summary:
11 Buy, 21 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 2
Join SI Premium – FREE
Jefferies analyst Raj Denhoy reiterated a Buy rating and lifted his price target on NuVasive (NASDAQ: NUVA) to $72.00 (from $63.00) following results.
Denhoy commented, "NuVasive put up a $2mn/$0.01 rev./EPS beat and raised guidance for the year. The top-line (+8.6% ex-FX, ex-NSO) was driven by continued positive trends in Hardware and Support (which will include Biotronic going forwards) and another very strong quarter for the international business (+33% ex-FX). FY16 sales guidance raised to $962mn and includes $27mn from Biotronic."
The firm raised FY 2016 EPS from $1.48 to $1.65 and FY 2017 EPS from $1.91 to $2.17.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $62.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Correction: Citi Upgrades Sirius XM Radio (SIRI) to Neutral
- Citi Downgrades ICICI Prudential Life Insurance Co Ltd. (IPRU:IN) to Neutral
- Ubisoft Entertainment SA (UBI:FP) (UBSFY) PT Lowered to EUR21.35 at Barclays
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!